Publications

Filter by year

Filter by type

Filter by year

Showing all years

Efficacy of an intervention to reduce stigma towards people with skin diseases among health and body care professionals - a randomized controlled trial

J. Traxler, C.C. Braren-von Stülpnagel, M. Augustin, M. Grosser, D. Roggenkamp, R. Sommer

People with skin disease often experience stigmatization in health and body care settings, significantly impacting their quality of life. This parallel-group randomized controlled trial evaluated a face-to-face group seminar aimed at reducing stigma towards people with skin disease among health and body care professionals (HBCPs).

PMID:
41546158
DOI:
https://doi.org/10.1111/ddg.16017

Wirksamkeit des Online-Programms „HautKompass“ zur Reduktion von Selbststigmatisierung - Ergebnisse einer randomisiert-kontrollierten Studie

J. Traxler

Oral presentation at the annual conference of the German Dermatological Association (DDG), Berlin, Germany

Digitale Versorgungskonzepte und die Rolle der therapeutischen Allianz in der Psychodermatologie

J. Traxler

Oral presentation presented at the Deutscher Kongress für Psychosomatische Medizin und Psychotherapie (DKPM), Berlin, Germany

Effectiveness of a Self-Compassion Programme to Reduce Self-Stigma in Chronic Skin Diseases: the HautKompass RCT

J. Traxler, C. F. Z. Stuhlmann, N. da Silva Burger, C. Stierle, V. Djamei, A. Darzina, M. Rudnik & R. Sommer

Oral presentation presented at the European Health Psychology Society (EHPS), Groningen, the Netherlands

Workshop: Stigmatisierung bei Hautpatient/-innen

R. Sommer

Workshop presented at the Fachsymposium Psychosomatik und
Psychotherapie, Gießen, Germany

Identification of Stigmatization and Relevant Predictors in People With Alopecia Areata and Androgenetic Alopecia: A Comparative Cross-sectional Study in German-speaking Countries and the USA

J. Kullab, C.F.Z. Stuhlmann, S. Ziehfreund, H. Wecker, T. Biedermann & A. Zink

Stigmatization of skin conditions like alopecia areata (AA) and androgenetic alopecia (AGA) impairs quality of life (QoL), but research is limited. The aim of this study was to compare stigmatization and QoL in individuals with AA and AGA in German-speaking (GS) and US samples and identify stigmatization predictors. 

PMID:
40026109
DOI:
https://doi.org/10.2340/actadv.v105.42278

Erfassung der Lebensqualität bei Säuglingen und Kleinkindern mit Hauterkrankungen – Validierung des deutschen InToDermQoL-Fragebogens

J. Traxler, M. Augustin, R. Sommer, S. Hoffmann, R. Fölster-Holst, M. Baumeister, P. Staubach, N. da Silva Burger & H. Ott

Poster presented at the conference of the German Dermatological Association (DDG), Berlin, Germany.

Interdisciplinary care in immune-mediated inflammatory diseases with skin manifestations within the WHO's people-centred healthcare framework

R. Sommer, M. Augustin

Commentary on “Experience of patients and healthcare practitioners with interdisciplinary care in immune-mediated inflammatory diseases with skin manifestations: A systematic scoping review”.

PMID:
40277207
DOI:
https://doi.org/10.1111/jdv.20640

Communication and Therapy Planning for Patients of Reproductive Age Under Immunomodulatory Treatments for Psoriasis or Psoriatic Arthritis-Survey of the German National Psoriasis Registry PsoBest

B. Stephan, C. Sorbe, B. Zyriax, J. Schmittinger, M. Augustin, R. Sommer, N. da Silva Burger, A. Weyergraf, R. von Kiedrowski, L. Kühl

During the systemic treatment of moderate to severe psoriasis in patients of reproductive age, contraindications and therapeutic peculiarities must be taken into account. Doctor-patient communication is crucial for therapy conduct and compliance. This survey among male and female patients from the German psoriasis registry, PsoBest, aims to provide real-world evidence on communication and patient needs for those of reproductive age (18-55).

PMID:
40361795
DOI:
https://www.mdpi.com/3289720

Benefits and Satisfaction with Apremilast Treatment in Patients with Psoriasis Affecting the Genital Area: Secondary Analysis of the APPRECIATE Study

N. da Silva Burger, K.V. Tran, M. Typou, R. Sommer, D. Neasham, M. Cordey & M. Augustin

Plaque-type psoriasis affects the genital area in 7–42% of patients, and can impose significant quality of life (QoL) impairments. In this case, systemic treatment is recommended regardless of the affected body surface area. This real-world study compared treatment effects and patient-reported outcomes (PROs) between patients with and without genital lesions, undergoing apremilast treatment for 6 ± 1 months. Secondary analyses were conducted using data from the observational, retrospective, cross-sectional APPRECIATE study. 

PMID:
39969771
DOI:
https://doi.org/10.1007/s13555-025-01360-y
1 2 3 4 5 6 … 26 > >>